Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
98 studies found for:    Lupus AND (woman OR women OR female)

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Lupus AND (woman OR women OR female)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Prasterone (GL701)
2 Completed Insulin Resistance and Atherosclerosis in Women With Lupus
Conditions: Systemic Lupus Erythematosus;   Insulin Resistance;   Atherosclerosis
Intervention:
3 Completed Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors
Condition: Systemic Lupus Erythematosus
Intervention: Drug: atorvastatin
4 Unknown † Estrogen and Gender Biased Autoimmunity
Condition: Systemic Lupus Erythematosus
Intervention: Other: Peripheral lab draws
5 Unknown † To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids
Condition: Lupus
Intervention: Drug: Prasterone (GL701)
6 Completed Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: pioglitazone;   Drug: placebo
7 Withdrawn Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female Patients
Condition: Systemic Lupus Erythematosus
Interventions: Drug: SAR113244;   Drug: placebo
8 Terminated
Has Results 		Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: simvastatin;   Drug: Comparator: Placebo
9 Completed Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients
Condition: Systemic Lupus Erythematosus
Interventions: Drug: SAR113244;   Drug: placebo
10 Completed A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus
Interventions: Drug: ABT-199;   Other: Placebo
11 Completed Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: estradiol;   Drug: ethinyl estradiol;   Drug: medroxyprogesterone;   Drug: norethindrone
12 Completed Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Gardasil
13 Completed Effect of Hormone Replacement Therapy on Lupus Activity
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d
14 Completed Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Dehydroepiandrosterone (DHEA)
15 Completed Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
Conditions: Systemic Lupus Erythematosus;   Lupus
Interventions: Drug: pravastatin;   Drug: aspirin;   Drug: ramipril;   Drug: Vitamins: B6, B12, and folate;   Behavioral: heart health educational program
16 Recruiting Preventive Approach to Congenital Heart Block With Hydroxychloroquine
Conditions: Congenital Heart Block;   Neonatal Lupus;   Autoantibody-Associated Heart Block
Intervention: Drug: Hydroxychloroquine
17 Completed Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:
18 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: dehydroepiandrosterone
19 Recruiting Belimumab (BENLYSTA®) Pregnancy Registry
Condition: Systemic Lupus Erythematosus
Intervention: Drug: belimumab
20 Completed Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: dehydroepiandrosterone
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years